1. Home
  2. PCQ vs RFL Comparison

PCQ vs RFL Comparison

Compare PCQ & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO California Municipal Income Fund

PCQ

PIMCO California Municipal Income Fund

SELL

Current Price

$8.01

Market Cap

155.6M

Sector

Finance

ML Signal

SELL

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

SELL

Current Price

$1.07

Market Cap

133.1M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
PCQ
RFL
Founded
2001
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Real Estate
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
155.6M
133.1M
IPO Year
2001
2017

Fundamental Metrics

Financial Performance
Metric
PCQ
RFL
Price
$8.01
$1.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 190.2K
52.3K
Earning Date
01-01-0001
12-10-2026
Dividend Yield
★ 4.63%
N/A
EPS Growth
N/A
★ 44.23
EPS
★ N/A
N/A
Revenue
N/A
★ $917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 43.96
52 Week Low
$7.57
$0.99
52 Week High
$9.19
$3.96

Technical Indicators

Market Signals
Indicator
PCQ
RFL
Relative Strength Index (RSI) 44.49 34.97
Support Level N/A $0.99
Resistance Level $9.16 $1.38
Average True Range (ATR) 0.11 0.10
MACD -0.02 0.02
Stochastic Oscillator 6.36 20.01

Price Performance

Historical Comparison
PCQ
RFL

About PCQ PIMCO California Municipal Income Fund

PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal, New York State, and New York City income tax. The fund invests across sectors including healthcare, property, education, Natural Gas, and others.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: